Acquisition Combines Hims & Hers’ Leading Wellness Platform with YourBio’s Patented, Virtually Painless Micro-Needle Technology to Redefine the Future of Blood Sampling SAN FRANCISCO & BOSTON, ...
The collaboration positions Neurogen at the forefront of globally building a scalable, home-based model for Alzheimer’s-related biomarker testing and cognitive-health services. Neurogen Biomarking and ...
SAN DIEGO--(BUSINESS WIRE)--Researchers from University of California San Diego School of Medicine will be providing the latest evidence from a recent evaluation of Truvian Health’s (Truvian’s) ...
Mursla Bio introduces AI Precision Medicine Platform built on organ-specific EV isolation from blood
Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to advance precision diagnostics and significantly improve cancer outcomes for at-risk patients, today announced the commercial ...
Organ transplantation involves the transplantation of organs from donors as a means to treat disease or injury, but there is a shortage of organs available for donation compared to the demand for ...
Truvian Health, maker of a benchtop blood-testing system, announced it had secured $74 million in capital and is partnering with Canada's largest pharmacy, Shoppers Drug Mart. Great Point Ventures and ...
Schematic of the microaneurysm-on-a-chip platform with eight microaneurysms of varying sizes (A). Bright-field image illustrating blood flow in the microchip (B). A zoomed-in view of two microaneurysm ...
Midline intravenous catheters (MCs) have been used in clinical settings since the 1950s and are an alternative for intravenous (IV) access for giving infusions and medications for long-term therapy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results